These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 15682416)

  • 1. T-cell-mediated pure red-cell aplasia in systemic lupus erythematosus: response to cyclosporin A and mycophenolate mofetil.
    Arcasoy MO; Chao NJ
    Am J Hematol; 2005 Feb; 78(2):161-3. PubMed ID: 15682416
    [No Abstract]   [Full Text] [Related]  

  • 2. A tale of autoimmunity: thymoma, thymectomy, and systemic lupus erythematosus.
    Mollaeian A; Haas C
    Clin Rheumatol; 2020 Jul; 39(7):2227-2234. PubMed ID: 32277368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Successful treatment of pure red cell aplasia associated with systemic lupus erythematosus with cyclosporin A.
    Duarte-Salazar C; Cazarín-Barrientos J; Goycochea-Robles MV; Collazo-Jaloma J; Burgos-Vargas R
    Rheumatology (Oxford); 2000 Oct; 39(10):1155-7. PubMed ID: 11035141
    [No Abstract]   [Full Text] [Related]  

  • 4. Mycophenolate mofetil-induced erythroid hypoplasia in a patient with systemic lupus erythematosus.
    Doherty T; Austin SK; Newell B; Kiely PD
    Lupus; 2013 Feb; 22(2):213-5. PubMed ID: 23257406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coexisting subacute and systemic lupus erythematosus after terbinafine administration: successful treatment with mycophenolate mofetil.
    Cetkovská P; Pizinger K
    Int J Dermatol; 2006 Mar; 45(3):320-2. PubMed ID: 16533240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of pure red cell aplasia in systemic lupus erythematosus with cyclosporin A.
    Atzeni F; Sarzi-Puttini P; Capsoni F; Vulpio L; Carrabba M
    Clin Exp Rheumatol; 2003; 21(6):759-62. PubMed ID: 14740456
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tacrolimus and pure red-cell aplasia.
    Gregoor PS; Weimar W
    Am J Transplant; 2005 Jan; 5(1):195-6. PubMed ID: 15636632
    [No Abstract]   [Full Text] [Related]  

  • 8. A case of pure red cell aplasia and immune thrombocytopenia complicating systemic lupus erythematosus: response to rituximab and cyclophosphamide.
    Gupta RK; Ezeonyeji AN; Thomas AS; Scully MA; Ehrenstein MR; Isenberg DA
    Lupus; 2011 Dec; 20(14):1547-50. PubMed ID: 21993386
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pure red cell aplasia associated with systemic lupus erythematosus.
    Koyama RV; Silva LF; Henriques VB; Tran C; Yoshikawa GT
    Acta Reumatol Port; 2014; 39(3):265-8. PubMed ID: 25326408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain diffuse large B-cell lymphoma in a systemic lupus erythematosus patient treated with immunosuppressive agents including mycophenolate mofetil.
    Svobodova B; Hruskova Z; Rysava R; Tesar V
    Lupus; 2011 Nov; 20(13):1452-4. PubMed ID: 21868432
    [No Abstract]   [Full Text] [Related]  

  • 11. Systemic lupus erythematosus with pure red cell aplasia: a case report.
    Tsai MH; Lee DT; Chen HC; Hsueh SC; Tseng CP
    Zhonghua Yi Xue Za Zhi (Taipei); 1993 Oct; 52(4):265-8. PubMed ID: 8258121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment of pure red cell aplasia in systemic lupus erythematosus with erythropoietin.
    Orbach H; Ben-Yehuda A; Ben-Yehuda D; Manor D; Rubinow A; Naparstek Y
    J Rheumatol; 1995 Nov; 22(11):2166-9. PubMed ID: 8596164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mycophenolate mofetil: a magic bullet for lupus?
    McCune WJ; Riskalla MM
    J Rheumatol; 2005 Jun; 32(6):967-70. PubMed ID: 15940751
    [No Abstract]   [Full Text] [Related]  

  • 14. Effective methylprednisolone "pulse" therapy in myeloerythroid aplasia associated with systemic lupus erythematosus: case report and literature review.
    Yamauchi K; Arimori S
    Tokai J Exp Clin Med; 1987 Dec; 12(5-6):337-41. PubMed ID: 3150137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bullous systemic lupus erythematosus responding to mycophenolate mofetil.
    Hamminga EA; Vermeer MH
    Eur J Dermatol; 2010; 20(6):844-5. PubMed ID: 20923751
    [No Abstract]   [Full Text] [Related]  

  • 16. Acquired pure red cell aplasia--a case report.
    Rahman J; Rashid MA; Yunus AB; Chowdhury SA; Kabir A; Khan MA; Wajed J
    Bangladesh Med Res Counc Bull; 1998 Dec; 24(3):79-81. PubMed ID: 10874372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycophenolate mofetil suppresses autoimmunity and mortality in the female NZB x NZW F1 mouse model of systemic lupus erythematosus.
    McMurray RW; Elbourne KB; Lagoo A; Lal S
    J Rheumatol; 1998 Dec; 25(12):2364-70. PubMed ID: 9858431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined pure red cell aplasia and autoimmune hemolytic anemia in systemic lupus erythematosus with anti-erythropoietin autoantibodies.
    Hara A; Wada T; Kitajima S; Toyama T; Okumura T; Kitagawa K; Iwata Y; Sakai N; Furuichi K; Higuchi M; Kaneko S
    Am J Hematol; 2008 Sep; 83(9):750-2. PubMed ID: 18626921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New trends in chemotherapy of systemic lupus erythematosus: treatment with mycophenolate mofetil].
    Shekshina SV; Kliukvina NG; Nasonov EL; Nasonova VA
    Klin Med (Mosk); 2002; 80(4):26-30. PubMed ID: 12043258
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A case of systemic lupus erythematosus complicated by pure red cell aplasia and idiopathic portal hypertension after thymectomy.
    Iwadate H; Kobayashi H; Shio K; Noguchi E; Watanabe K; Sasajima T; Sekine H; Watanabe H; Ohira H; Obara K; Sato Y
    Mod Rheumatol; 2006; 16(2):109-12. PubMed ID: 16633932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.